In the study, the new approach extended overall survival by nearly two months compared to conventional treatments.

But we are sequentially extending survival a year or two at a time, which is not trivial.

In some cases the device extended survival by several months, allowing the patients to spend valuable time with family and friends.

In two cases, the device extended survival by 10 and 17 months respectively, and one patient was discharged from the hospital to go home.

The drug extends survival but does not cure the disease.

It has been shown to extend survival in these patients.

But the main goal of the trial was to extend survival.

To date, no salvage regimen has been shown to extend survival.

The role of the treatment, he says, is to extend survival a bit longer when other treatment options have failed.

For those people who cannot be cured, modern treatment can significantly improve quality of life and may extend survival.